Google ships agentic AI governance tools while Harvard study shows AI beats doctors

Google announced native agentic AI governance controls as a product at Cloud Next '26 in Las Vegas two weeks ago. The platform addresses enterprise deployment challenges that the industry has avoided for two years.

IT leaders and compliance teams should audit current AI governance processes. Request a demo within 7 days to benchmark against your internal tooling costs and timeline.

A Harvard study tested large language models against human emergency room doctors on real cases. At least one AI model demonstrated higher diagnostic accuracy than the human physicians.

Healthcare executives and medical directors should review current AI-assisted diagnosis policies. Schedule legal review of malpractice coverage for AI-recommended treatments before month-end.

Belgian pharma UCB will acquire Candid Therapeutics for $2.2 billion to gain access to bispecific antibody drugs. The portfolio includes T cell engager therapies licensed from Chinese biotechs for autoimmune diseases.

Pharma business development teams should map current T cell engager partnerships and licensing deals. Reassess autoimmune pipeline priorities against this valuation benchmark by Friday.

KC Green, creator of the 'This is Fine' meme, accused AI startup Artisan of using his artwork without permission in advertising. Artisan runs billboards urging businesses to 'stop hiring humans.'

Legal teams using AI-generated content should audit current image and creative workflows. Implement artist attribution checks for all AI-generated marketing materials this week.

Former Latham & Watkins lawyer Will Chen launched Mike, an open source legal AI platform. Social media posts about the platform have surged since the launch.

Legal IT directors should evaluate open source versus commercial legal AI trade-offs. Download Mike for testing in a sandboxed environment before committing to paid platforms.